D-0014-2026 Class II Ongoing

Recalled by Acella Pharmaceuticals, LLC — Alpharetta, GA

FDA drug recall D-0014-2026 was initiated by Acella Pharmaceuticals, LLC on Sep 29, 2025 and is designated Class II. Reason for recall: Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications. The recall status is ongoing. Affected quantity: 4,680 500-count bottles.

Recall details

Product Type
Drugs
Report Date
Oct 15, 2025
Initiation Date
Sep 29, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,680 500-count bottles

Product description

Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-501-05.

Reason for recall

Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.

Distribution pattern

Nationwide in the USA

Code information

Lot #: P24ZLK1, Exp 5/31/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0014-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0014-2026. Report a data issue: hello@regdatalab.com.